Western Pacific Wealth Management, LP Crispr Therapeutics Ag Transaction History
Western Pacific Wealth Management, LP
- $98.7 Million
- Q2 2025
A detailed history of Western Pacific Wealth Management, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 500 shares of CRSP stock, worth $36,535. This represents 0.02% of its overall portfolio holdings.
Number of Shares
500
Previous 1,000
50.0%
Holding current value
$36,535
Previous $34,000
29.41%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
535Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$744 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$409 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$269 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$239 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$208 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.7B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....